278 related articles for article (PubMed ID: 24932571)
41. Genome-wide profiling of the PIWI-interacting RNA-mRNA regulatory networks in epithelial ovarian cancers.
Singh G; Roy J; Rout P; Mallick B
PLoS One; 2018; 13(1):e0190485. PubMed ID: 29320577
[TBL] [Abstract][Full Text] [Related]
42. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival.
Rosen DG; Wang L; Jain AN; Lu KH; Luo RZ; Yu Y; Liu J; Bast RC
Clin Cancer Res; 2004 Oct; 10(19):6559-66. PubMed ID: 15475444
[TBL] [Abstract][Full Text] [Related]
43. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
[TBL] [Abstract][Full Text] [Related]
44. Piwi proteins and piRNAs in mammalian oocytes and early embryos.
Roovers EF; Rosenkranz D; Mahdipour M; Han CT; He N; Chuva de Sousa Lopes SM; van der Westerlaken LA; Zischler H; Butter F; Roelen BA; Ketting RF
Cell Rep; 2015 Mar; 10(12):2069-82. PubMed ID: 25818294
[TBL] [Abstract][Full Text] [Related]
45. Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer.
Zhang P; Zhang P; Zhou M; Jiang H; Zhang H; Shi B; Pan X; Gao H; Sun H; Li Z
Carcinogenesis; 2013 Nov; 34(11):2639-46. PubMed ID: 23764753
[TBL] [Abstract][Full Text] [Related]
46. Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.
Xie K; Zhang K; Kong J; Wang C; Gu Y; Liang C; Jiang T; Qin N; Liu J; Guo X; Huo R; Liu M; Ma H; Dai J; Hu Z
Cancer Med; 2018 Jan; 7(1):157-166. PubMed ID: 29168346
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for arginine methylation-independent recognition of PIWIL1 by TDRD2.
Zhang H; Liu K; Izumi N; Huang H; Ding D; Ni Z; Sidhu SS; Chen C; Tomari Y; Min J
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12483-12488. PubMed ID: 29118143
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological values of NBS1 and DNA damage response genes in epithelial ovarian cancers.
Lee YK; Park NH; Lee H
Exp Mol Med; 2015 Nov; 47(11):e195. PubMed ID: 26584681
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA‑139 suppressed tumor cell proliferation, migration and invasion by directly targeting HDGF in epithelial ovarian cancer.
Liu J; Jin S; Wang R
Mol Med Rep; 2017 Sep; 16(3):3379-3386. PubMed ID: 28713954
[TBL] [Abstract][Full Text] [Related]
50. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
51. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
52. SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
Lim W; Kim HS; Jeong W; Ahn SE; Kim J; Kim YB; Kim MA; Kim MK; Chung HH; Song YS; Bazer FW; Han JY; Song G
PLoS One; 2012; 7(11):e49869. PubMed ID: 23185467
[TBL] [Abstract][Full Text] [Related]
53. ETV5 transcription factor is overexpressed in ovarian cancer and regulates cell adhesion in ovarian cancer cells.
Llauradó M; Abal M; Castellví J; Cabrera S; Gil-Moreno A; Pérez-Benavente A; Colás E; Doll A; Dolcet X; Matias-Guiu X; Vazquez-Levin M; Reventós J; Ruiz A
Int J Cancer; 2012 Apr; 130(7):1532-43. PubMed ID: 21520040
[TBL] [Abstract][Full Text] [Related]
54. MiR-135a functions as a tumor suppressor in epithelial ovarian cancer and regulates HOXA10 expression.
Tang W; Jiang Y; Mu X; Xu L; Cheng W; Wang X
Cell Signal; 2014 Jul; 26(7):1420-6. PubMed ID: 24607788
[TBL] [Abstract][Full Text] [Related]
55. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
56. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
[TBL] [Abstract][Full Text] [Related]
57. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
58. piRNA-independent function of PIWIL1 as a co-activator for anaphase promoting complex/cyclosome to drive pancreatic cancer metastasis.
Li F; Yuan P; Rao M; Jin CH; Tang W; Rong YF; Hu YP; Zhang F; Wei T; Yin Q; Liang T; Wu L; Li J; Li D; Liu Y; Lou W; Zhao S; Liu MF
Nat Cell Biol; 2020 Apr; 22(4):425-438. PubMed ID: 32203416
[TBL] [Abstract][Full Text] [Related]
59. PDCD6 is an independent predictor of progression free survival in epithelial ovarian cancer.
Su D; Xu H; Feng J; Gao Y; Gu L; Ying L; Katsaros D; Yu H; Xu S; Qi M
J Transl Med; 2012 Feb; 10():31. PubMed ID: 22369209
[TBL] [Abstract][Full Text] [Related]
60. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
Zhang Y; Zhao FJ; Chen LL; Wang LQ; Nephew KP; Wu YL; Zhang S
Oncotarget; 2014 Dec; 5(23):12291-303. PubMed ID: 25460499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]